Relationship between plasma B-type natriuretic peptide and ventricular function in adult cardiac surgery patients

Journal of International Medical Research

Volumn 36, Issue 1, 2008, Pages 31-39

  Jeong, D S ^a   Kim, Kyung Hwan ^a   Kim, C Y ^b   Kim, J S ^a  

^a Seoul National University Hospital   (South Korea)

^b Inje University College of Medicine   (South Korea)

Author keywords

B type natriuretic peptide; Cardiac surgery; Left ventricular dysfunction

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; AORTA DISEASE; ARTICLE; BACTERIAL ENDOCARDITIS; BLOOD LEVEL; CARDIAC PATIENT; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART SURGERY; HEART VENTRICLE FUNCTION; HUMAN; MALE; MITRAL VALVE REPLACEMENT; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; VALVULAR HEART DISEASE;

EID: 39149093997     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000803600105     Document Type: Article

References (16)

1. Stein BC, Levin RI: Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease. Am Heart J 1998; 135: 914-923.
2. Sudoh T, Kangawa K, Minamino N, et al: A new notriuretic peptide in porcine brain. Nature 1988; 332: 78-81.
3. Bobadilla RV, Oppelt TF, Hirshy TC: Nesiritide treatment of noncardiogenic pulmonary edemo. Ann Pharmacother 2003; 37: 530-533.
4. Michaels AD, Klein A, Madden JA, et al: Effects of intravenous nesiritide on human coronary vasomotor regulation and myocardial oxygen uptake. Circulation 2003; 107: 2697-2701.
5. Rayburn BK, Bourge RC: Nesiritide: a unique therapeutic cardiac peptide. Rev Cardiovasc Med 2001; 2(suppl 2): S25-S31.
6. Murdoch DR, Byrne J, Morton JJ, et al: Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practice. Heart 1997; 78: 594-597.
7. Brookes CI, Kemp MW, Hooper J, et al: Plasma brain natriuretic peptide concentrations in patients with chronic mitral regurgitation. J Heart Valve Dis 1997; 6: 608-612.
8. Talwar S, Downie PF, Squire IB, et al: Plasma N-terminal pro BNP and cardiotrophin-1 are elevated in aortic stenosis. Eur J Heart Fail 2001; 3: 15-19.
9. Qi W, Mathisen P, Kjekshus J, et al: Natriuretic peptides in patients with aortic stenosis. Am Heart J 2001; 142: 725-732.
10. Tanaka H, Shindo M, Gutkowska I, et al: Effect of acute exercise on plasma immunoreactive atrial natriuretic factor. Life Sci 1986; 39: 1685-1693.
11. Suzuki E, Hirata Y, Kohmoto O, et al: Cellular mechanisms for synthesis and secretion of atrial natriuretic peptide and brain natriuretic peptide in cultured rat atrial cells. Circ Res 1992; 71: 1039-1048.
12. McGregor A, Richards M, Espiner E, et al: Brain natriuretic peptide administered to man: actions and metabolism. J Clin Endocrinol Metab 1990; 70: 1103-1107.
13. Lang CC, Motwani J, Coutie WJ, et al: Influence of candoxatril on plasma brain natriuretic peptide in heart failure. Lancet 1991; 338: 255.
14. Ikeda T, Matsuda K, Itoh H, et al: Plasma levels of brain and atrial natriuretic peptides elevate in proportion to left ventricular end-systolic wall stress in patients with aortic stenosis. Am Heart J 1997; 133: 307-314.
15. Morimoto K, Mori T, Ishiguro S, et al: Perioperative changes in plasma brain natriuretic peptide concentrations in patients undergoing cardiac surgery. Surg Today 1998; 28: 23-39.
16. Morrison LK, Harrison A, Krishnaswamy P, et al: Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 2002; 39: 202-209.